Talat Imran
CEO at Rani Therapeutics Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Rani Therapeutics Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rani Therapeutics Holdings Inc. May 28, 202699.7%
-
Rani Therapeutics Holdings Inc. May 28, 202599.9%
-
Rani Therapeutics Holdings Inc. May 29, 2024100.0%
-
Rani Therapeutics Holdings Inc. May 25, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 27, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −7,928 | $0.76 | $6,025 |
| Jul 17, 2026 | Rani Therapeutics Holdings Inc. | Open-market purchase | +35,000 | $0.72 | $25,200 |
| Jun 27, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −7,927 | $0.74 | $5,866 |
| Mar 27, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,099 | $0.81 | $7,370 |
| Mar 22, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −8,916 | $1.13 | $10,075 |
| Dec 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −7,906 | $1.40 | $11,068 |
| Sep 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,077 | $0.48 | $4,357 |
| Jun 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,076 | $0.55 | $4,992 |
| Dec 27, 2024 | Rani Therapeutics Holdings Inc. | Open-market sale | −8,014 | $1.41 | $11,300 |
| Dec 9, 2024 | Rani Therapeutics Holdings Inc. | Open-market purchase | +10,296 | $1.94 | $19,974 |
| Dec 6, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +10,000 | $2.27 | $22,700 |
| Dec 4, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +5,000 | $2.57 | $12,850 |
| Nov 29, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +20,000 | $2.05 | $41,000 |
| Nov 7, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +2,500 | $1.98 | $4,950 |
| Nov 7, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +2,500 | $2.01 | $5,025 |
Questions about Talat Imran
What boards is Talat Imran on?
Talat Imran sits on the board of Rani Therapeutics Holdings Inc.
What company is Talat Imran the CEO of?
Talat Imran is CEO of Rani Therapeutics Holdings Inc.
How long has Talat Imran served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.